Back to Search
Start Over
Combining Aloin with TIENAM ameliorates cecal ligation and puncture-induced sepsis in mice by attenuating inflammation and modulating abdominal cavity microbiota.
- Source :
-
International immunopharmacology [Int Immunopharmacol] 2024 Nov 15; Vol. 141, pp. 112925. Date of Electronic Publication: 2024 Aug 17. - Publication Year :
- 2024
-
Abstract
- Despite the high mortality rate, sepsis lacks specific and effective treatment options. Conventional antibiotics, such as TIENAM (TIE; imipenem and cilastatin sodium for injection), face challenges owing to the emergence of bacterial resistance, which reduces their effectiveness and causes adverse effects. Addressing resistance and judicious drug use is crucial. Our research revealed that aloin (Alo) significantly boosts survival rates and reduces inflammation and bacterial load in mice with sepsis, demonstrating strong antimicrobial activity. Using a synergistic Alo + TIE regimen in a cecal ligation and puncture (CLP)-induced sepsis model, we observed a remarkable increase in survival rates from 10 % to 75 % within 72 h compared with the CLP group alone. This combination therapy also modulated inflammatory markers interleukin (IL)-6, IL-1β, and tumor necrosis factor (TNF)-α, mitigated tissue damage, regulated immune cells by lowering NK, activated CD8 <superscript>+</superscript> and CD4 <superscript>+</superscript> T cells while increasing peritoneal macrophages, and decreased the bacterial load in the peritoneal cavity. We noted a significant shift in the abdominal cavity microbiota composition post-treatment, with a decrease in harmful bacteria, such as Lachnospiraceae&#95;NK4A136&#95;group, Klebsiella, Bacillus, and Escherichia, and an increase in beneficial bacteria, such as Lactobacillus and Mucispirillum. Our study emphasizes the efficacy of combining Alo with TIE to combat sepsis, and paves the way for further investigations and potential clinical applications aiming to overcome the limitations of TIE and enhance the therapeutic prospects of Alo.<br />Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Jingqian Su reports financial support was provided by National Natural Science Foundation of China. Jingqian Su reports financial support was provided by Natural Science Foundation of Fujian Province. Jingqian Su reports financial support was provided by Fujian Provincial Regional Development Project.<br /> (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Subjects :
- Animals
Mice
Male
Ligation
Anti-Bacterial Agents therapeutic use
Anti-Bacterial Agents pharmacology
Punctures
Disease Models, Animal
Imipenem therapeutic use
Imipenem pharmacology
Cytokines metabolism
Drug Therapy, Combination
Gastrointestinal Microbiome drug effects
Anti-Inflammatory Agents therapeutic use
Anti-Inflammatory Agents pharmacology
Inflammation drug therapy
Microbiota drug effects
Bacterial Load drug effects
Sepsis drug therapy
Sepsis immunology
Sepsis microbiology
Emodin pharmacology
Emodin therapeutic use
Emodin analogs & derivatives
Cecum surgery
Cecum microbiology
Mice, Inbred C57BL
Subjects
Details
- Language :
- English
- ISSN :
- 1878-1705
- Volume :
- 141
- Database :
- MEDLINE
- Journal :
- International immunopharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 39154534
- Full Text :
- https://doi.org/10.1016/j.intimp.2024.112925